Pfizer’s Phase III Study Demostrate 95% Efficacy


One of the most likely vaccine candidates for the corona virus vaccine, the US pharmaceutical company Pfizer Inc, has a big claim on the vaccine. The company said that the Phase III study of our Covid-19 vaccine has met all the key points. The study reached 170 confirmed cases of Kovid-19. The vaccine candidate BNT163B2 (BNT162b2) showed a 95% effective onset 28 days after the first dose.

Disclaimer :- This post is independently published by the author. Infeed neither backs nor assumes liability for the opinions put forth by the author.

Share post:



More like this

A Global Perspective of Assistive Technology for Differently-Abled People (Divyangjan)

Assistive technology plays a crucial role in empowering individuals...

मीडिया, प्रधानमंत्री, लोकतंत्र, नई संसद और साम्यवाद

एक खबर आती है- "पेंटागन में US के रक्षा...

An Ugly Reality: Disrespect Towards Artists in Tollywood

Bengal Film Industry (Tollywood) has again witnessed an incident...

We Need New Parliament Ethos Before A New Parliament Building

9 years ago, when Narendra Modi and his party...